Treatment of hepatocellular carcinoma (HCC) is dependent on the stage of the disease.
Intermediate stage HCC encompasses the largest subgroup of patients with the disease …

Many patients with hepatocellular carcinoma (HCC) present with advanced disease, not
amenable to curative therapies such as surgery, transplantation or radiofrequency ablation …

Primary liver cancer includes hepatocellular carcinoma (HCC, 75–85%) and intrahepatic
cholangiocarcinoma (10–15%). The vast majority of patients with primary HCC are not …

Simple Summary Ablation, arterially directed therapies and external beam radiation therapy
are among the locoregional therapies considered for patients with hepatocellular carcinoma …

The incidence of hepatocellular carcinoma continues to increase worldwide. Fortunately,
there have been notable recent advances in locoregional and systemic therapy. In this …

Purpose Hepatocellular carcinoma (HCC) involving inferior vena cava (IVC) and/or right
atrium (RA) is a very rare but serious disease. The objective of this meta-analysis was to …

Although tumor thrombus (TT) infringement of the inferior vena cava (IVC) and right atrium
(RA) is rarely observed in hepatocellular carcinoma (HCC), the prognosis for this condition …

Purpose: Hepatocellular carcinoma (HCC) involving the inferior vena cava (IVC) and/or right
atrium (RA) can affect systemic circulation, causing fatal complications. Standard treatment …

The liver tumor immune microenvironment has been thought to possess a critical role in the
development and progression of hepatocellular carcinoma (HCC). Despite the approval of …

Background: Hepatocellular carcinoma (HCC) management has evolved over the past two
decades, with the development of newer treatment modalities. While various options are …